Skip to main content

FOUNDERS CAPITAL MANAGEMENT, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1585828 Hartford, CT

Position in REGN

as of Jun 30, 2026 · filed Jul 20, 2026
Position Value
$5,228,382
-$1,109,583 QoQ
Shares Held
8,385
+2.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#384
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FOUNDERS CAPITAL MANAGEMENT, LLC holds $5,438,472 across 2 Biotechnology names. REGN ranks #1 (96.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
8,385 $5,228,382

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,228,382 8,385
2026-03-31 $6,337,965 8,203
2025-12-31 $6,331,649 8,203
2025-09-30 $4,653,908 8,277
2025-06-30 $4,343,850 8,274
2025-03-31 $4,906,403 7,736
2024-12-31 $5,675,845 7,968
2024-09-30 $8,128,187 7,732
2024-06-30 $8,182,268 7,785
2024-03-31 $7,544,959 7,839
2023-12-31 $6,884,915 7,839
2023-09-30 $6,531,833 7,937
2023-06-30 $5,771,313 8,032
2023-03-31 $6,711,400 8,168
2022-12-31 $5,981,152 8,290
2022-09-30 $5,858,839 8,505
2022-06-30 $5,090,220 8,611
2022-03-31 $5,997,332 8,587
2021-12-31 $5,369,814 8,503
2021-09-30 $5,324,978 8,799
2021-06-30 $4,982,735 8,921
2021-03-31 $1,854,708 3,920
2020-12-31 $278,754 577
2020-09-30 $322,993 577
2020-06-30 $359,846 577
2020-03-31 $281,743 577